跳至主要内容
临床试验/NCT01442948
NCT01442948已完成不适用

CD16+ Monocytes in Patients With Coronary Heart Disease

Martin-Luther-Universität Halle-Wittenberg1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2007年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,000
试验地点
1
主要终点
Absolute numbers of CD16+ monocytes stratified by tertiles related to the incidence of the combined endpoint

研究概览

简要总结

Monocytes may be separated into phenotypically and functionally distinct cell types by the presence or absence of the lipopolysaccharide receptor CD14 and the Fcγ-receptor CD16. The investigators hypothesize that the total numbers of CD16+ monocytes are significantly related to cardiovascular outcome in patients with angiographically proven coronary heart disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • angiographically proven coronary heart disease
  • Age > 18 years

排除标准

  • life expectancy < 12 months
  • inability to participate in the trial (to give written informed consent)

结局指标

主要结局

Absolute numbers of CD16+ monocytes stratified by tertiles related to the incidence of the combined endpoint

时间窗: 12 months

Incidence of the combined endpoint (non-fatal myocardial infarction, cardiovascular death, stroke) during a follow-up of 12 months

次要结局

  • Absolute numbers of CD16+ monocytes stratified by tertiles related to the incidence of each part of the combined endpoint + total death(12 months)
  • Subgroup analysis for absolute numbers of CD16+ monocytes stratified by tertiles in relation to the combined endpoint(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Axel Schlitt

Senior Physician

Martin-Luther-Universität Halle-Wittenberg

研究点 (1)

Loading locations...

相似试验